Figure S2. The pooled MD of serum lactate (A), serum ionized calcium (B) and total calcium (C), and the pooled RD of ionized hypocalcemia (D) between the start of CRRT and the end of observation. All the results were demonstrated in forest plot. CI, confidence interval; G1 group 1, G2 group 2, G3 group 3, G4 group 4; MD, mean difference; M, mild liver failure group; RD, risk difference; S, Severe liver failure group. (TIF 5817 kb
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT)...
Full list of author information is available at the end of the articleIntroduction Acute kidney inju...
Additional file 1. Table S1 Distribution of continuous renal replacement therapy modalities, by coro...
Figure S3. The pooled MD of pH (A), serum lactate (B) and totCa/ionCa ratio (C) between the liver fa...
Figure S1. The pooled MD of BE (A), the pooled rates of metabolic alkalosis (B), and the pooled RD o...
Table S1. The Modified version of the Newcastle-Ottawa Scale for assessing the quality of nonrandomi...
Table S3. Management of metabolic complications and citrate accumulation. (DOCX 20 kb
TSA for bleeding events and HIT. A Fixed-effect model of trial sequential analysis for bleeding even...
<b><i>Background/Aims:</i></b> Continuous renal replacement therapy (CRRT) is a treatment for acute ...
Publication bias for the primary outcomes. A Begg's funnel plot for mortality. b Begg's funnel plot ...
Abstract Background Regional citrate anticoagulation (RCA) is a widely used strategy for continuous ...
Background/Aims: Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury ...
Additional file 1: Table S1 Results of administration route and cell type of MSCs therapy on MELD sc...
Additional file 1. Figure S1: Forest plot of secondary indicators: (A): ALT levels (B): AST levels. ...
Figure S1. Forest plots showing the results of subgroup analysis result of SVR12/24 in dialysis-depe...
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT)...
Full list of author information is available at the end of the articleIntroduction Acute kidney inju...
Additional file 1. Table S1 Distribution of continuous renal replacement therapy modalities, by coro...
Figure S3. The pooled MD of pH (A), serum lactate (B) and totCa/ionCa ratio (C) between the liver fa...
Figure S1. The pooled MD of BE (A), the pooled rates of metabolic alkalosis (B), and the pooled RD o...
Table S1. The Modified version of the Newcastle-Ottawa Scale for assessing the quality of nonrandomi...
Table S3. Management of metabolic complications and citrate accumulation. (DOCX 20 kb
TSA for bleeding events and HIT. A Fixed-effect model of trial sequential analysis for bleeding even...
<b><i>Background/Aims:</i></b> Continuous renal replacement therapy (CRRT) is a treatment for acute ...
Publication bias for the primary outcomes. A Begg's funnel plot for mortality. b Begg's funnel plot ...
Abstract Background Regional citrate anticoagulation (RCA) is a widely used strategy for continuous ...
Background/Aims: Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury ...
Additional file 1: Table S1 Results of administration route and cell type of MSCs therapy on MELD sc...
Additional file 1. Figure S1: Forest plot of secondary indicators: (A): ALT levels (B): AST levels. ...
Figure S1. Forest plots showing the results of subgroup analysis result of SVR12/24 in dialysis-depe...
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT)...
Full list of author information is available at the end of the articleIntroduction Acute kidney inju...
Additional file 1. Table S1 Distribution of continuous renal replacement therapy modalities, by coro...